A video recently released by Amber Lyon of reset.me makes a well presented case for the medicinal use of psychedelics in modern society, extolling its virtues while simultaneously dispelling prevalent myths about the physical danger of of taking the drugs.
The FDA recently approved the use of Naloxone as a prescription treatment in the household for use in the case of an opioid overdose, in the form of an intramuscular auto-injector – similar to EpiPens (epinephrine) carried by those with severe allergies. Continue reading FDA Approves New Naloxone Treatment
A study recently completed at the University of New Mexico has shown that psychedelic drugs such as psilocybin and LSD have promise in the treatment of alcoholism and other forms of addiction. The study showed, that while there was a large range of resulting effects, conditions of addicts had improved overall.
This shows a resurgence of the type of medical research undertaken on psychedelics during the 50/60s, which has since been marred by public and institutional stigma, and comes as part of a neo-slew of parallel investigations into the potentially positive effects of psychedelic drugs.
TripSit was featured on MAPS Spring newsletter, released today.
MAPS (The Multidisciplinary Association
For Psychedelic Studies) is a non-profit organisation which researches
the use of drugs, and work towards a world whereby humanity may benefit
from the responsible and careful use of drugs. They particularly
champion the cause of marijuana and MDMA for medical purposes, and have
already had much success in initiating studies in MDMA and Marijuana
assisted psychotherapy worldwide.
After four years of work by charities such as MAPS, a licence was obtained last year to import nine grams of MDMA into Canada for the purposes of undertaking studies and treatments in MDMA-assisted psychotherapy for the treatment of PTSD. Continue reading Canada Approves MDMA for Clinical Research